Citations

Clear

4801 citation(s) found for "Yu, Jennifer".

Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign
Josephs, Kennedy A., Pham, Nha Trang Thu, Graff‐Radford, Jonathan , Lowe, Val J. , Whitwell, Jennifer L., Machulda, Mary M. , Whitwell, Jennifer

Mayo Clinic

Journal of Alzheimer's Disease | January 18, 2022 | Volume: 86 | Issue: 1 | Pages: 491-498

10.3233/jad-215263 | PMID 35068459 Get It

Background: It has been hypothesized that medial temporal sparing may be related to preserved posterior cingulate metabolism and the cingulate island sign (CIS) on [18F]fluorodeoxyglucose (FDG) PET in posterior cortical atrophy (PCA). Objective: To assess the severity of medial temporal atrophy in PCA and determine whether the presence of a CIS is related to medial temporal sparing. Methods: Fifty-five PCA patients underwent MRI and FDG-PET. The degree and symmetry of medial temporal atrophy on MRI was visually assessed using a five-point scale for both hemispheres. Visual assessments of FDG-PET coded the presence/absence of a CIS and whether the CIS was symmetric or asymmetric. Hippocampal volumes and a quantitative CIS were also measured. Results: Medial temporal atrophy was most commonly mild or moderate, was symmetric in 55% of patients, and when asymmetric was most commonly worse on the right (76%). Older age and worse memory performance were associated with greater medial temporal atrophy. The CIS was observed in 44% of the PCA patients and was asymmetric in 50% of these. The patients with a CIS showed greater medial temporal asymmetry, but did not show lower medial temporal atrophy scores, compared to those without a CIS. Hippocampal volumes were not associated with quantitative CIS. Conclusion: Mild medial temporal atrophy is a common finding in PCA and is associated with memory impairment. However, medial temporal sparing was not related to the presence of a CIS in PCA.
Optimizing the nutrition support care model: Analysis of survey data
Mundi, Manpreet S. , Mechanick, Jeffrey I. , Patel, Jayshil J. , Bonnes, Sara L. , Blackmer, Allison B. , Christian, Vikram J. , Hennessy, Sara A. , Jain, Ajay K. , Kaspar, M., Katz, Jennifer , Labossiere, Reginald, Limketkai, Berkeley N. , Morrison, Chet A. , Newberry, Carolyn , Mohamed Elfadil, Osman , Patel, Jayshil J , Christian, Vikram J , Hurt, Ryan T. , Jain, Ajay , Limketkai, Berkeley N , Morrison, Chet A , Pimiento, Jose M , Rosenthal, Martin , Taylor, Beth , McClave, Stephen A , Mechanick, Jeffrey I. , Mundi, Manpreet S , Elfadil, Osman Mohamed , Kaspar, Matthew B., Katz, Jennifer, McCarthy, Paul Joseph , Pimiento, José M. , Rosenthal, Martin D. , Taylor, Beth , McClave, Stephen A.

Mayo Clinic

Journal of Parenteral and Enteral Nutrition | January 18, 2022 | Volume: 46 | Issue: 7 | Pages: 1709-1724

10.1002/jpen.2326 | PMID 35040154 Get It

AbstractBackgroundMalnutrition is underrecognized and underdiagnosed, despite high prevalence rates and associated poor clinical outcomes. The involvement of clinical nutrition experts, especially physicians, in the care of high‐risk patients with malnutrition remains low despite evidence demonstrating lower complication rates with nutrition support team (NST) management. To facilitate solutions, a survey was designed to elucidate the nature of NSTs and physician involvement and identify needs for novel nutrition support care models.MethodsThis survey assessed demographics of NSTs, factors contributing to the success of NSTs, elements of nutrition education, and other barriers to professional growth.ResultsOf 255 respondents, 235 complete surveys were analyzed. The geographic distribution of respondents correlated with population concentrations of the United States (r = 90.8%, p < .0001). Most responding physicians (46/57; 80.7%) reported being a member of NSTs, compared with 56.5% (88/156) of dietitians. Of those not practicing in NSTs (N = 81/235, 34.4%), 12.3% (10/81) reported an NST was previously present at their institution but had been disbanded. Regarding NSTs, financial concerns were common (115/235; 48.9%), followed by leadership (72/235; 30.6%), and healthcare professional (HCP) interest (55/235; 23.4%). A majority (173/235; 73.6%) of all respondents wanted additional training in nutrition but reported insufficient protected time, ability to travel, or support from administrators or other HCPs.ConclusionCore actions resulting from this survey focused on formalizing physician roles, increasing interdisciplinary nutrition support expertise, utilizing cost‐effective screening for malnutrition, and implementing intervention protocols. Additional actions included increasing funding for clinical practice, education, and research, all within an expanded portfolio of pragmatic nutrition support care models.
Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach
Cho, May T., Gholami, Sepideh , Gui, Dorina , Tejaswi, Sooraj , Abi‐Jaoudeh, Nadine , Jutric, Zeljka , Samarasena, Jason , Li, Xiaodong , Valerin, Jennifer Brooke, Mercer, Jacob , Dayyani, Farshid , Achilonu, Conrad Chibunna , Fananapazir, Ghaneh , Mercer, Jacob , Dayyani, Farshid , Abi-Jaoudeh, Nadine , Achilonu, Conrad C , Cho, May

Mayo Clinic

Cancers | January 13, 2022 | Volume: 14 | Issue: 2 | Pages: 392

10.3390/cancers14020392 | PMID 35053557 Get It

Cholangiocarcinoma (CCA) is a heterogenous group of malignancies originating in the biliary tree, and associated with poor prognosis. Until recently, treatment options have been limited to surgical resection, liver-directed therapies, and chemotherapy. Identification of actionable genomic alterations with biomarker testing has revolutionized the treatment paradigm for these patients. However, several challenges exist to the seamless adoption of precision medicine in patients with CCA, relating to a lack of awareness of the importance of biomarker testing, hurdles in tissue acquisition, and ineffective collaboration among the multidisciplinary team (MDT). To identify gaps in standard practices and define best practices, multidisciplinary hepatobiliary teams from the University of California (UC) Davis and UC Irvine were convened; discussions of the meeting, including optimal approaches to tissue acquisition for diagnosis and biomarker testing, communication among academic and community healthcare teams, and physician education regarding biomarker testing, are summarized in this review.
Community-Engaged Bidirectional Crisis and Emergency Risk Communication With Immigrant and Refugee Populations During the COVID-19 Pandemic
Asiedu, Gladys B. , Njeru, Jane W. , Weis, Jennifer A., Lantz, Kiley, Abbenyi, Adeline, Molina, Luz, Ahmed, Yahye, Goodson, Miriam, Torres-Herbeck, Gloria, Nur, Omar, Capetillo, Graciela Porraz, Mohamed, Ahmed A. , Sia, Irene G. , Wieland, Mark L , Porraz Capetillo, Graciela, Sia, Irene G , Wieland, Mark L. , Osman, Ahmed

Mayo Clinic

Public Health Reports® | January 13, 2022 | Volume: 137 | Issue: 2 | Pages: 352-361

10.1177/00333549211065514 | PMID 35023414 Get It

Objectives: This study was conducted to assess an intervention that was created by a community–academic partnership to address COVID-19 health inequities. We evaluated a community-engaged bidirectional pandemic crisis and emergency risk communication (CERC) framework with immigrant and refugee populations during the COVID-19 pandemic. Methods: A 17-year community-engaged research partnership adopted a CERC framework in March 2020 to address COVID-19 prevention, testing, and socioeconomic impacts with immigrant and refugee groups in southeast Minnesota. The partnership used bidirectional communication between communication leaders and their social networks to refine messages, leverage resources, and advise policy makers. We conducted a mixed-methods evaluation for intervention acceptability, feasibility, reach, adaptation, and sustainability through multisource data, including email communications, work group notes, semistructured interviews, and focus groups. Results: The intervention reached at least 39 000 people in 9 months. It was implemented as intended and perceived efficacy was high. Frequent communication between community and academic partners allowed the team to respond rapidly to concerns and facilitated connection of community members to resources. Framework implementation also led to systems and policy changes to meet the needs of immigrant and refugee populations. Conclusions: Community-engaged CERC is feasible and sustainable and can reduce COVID-19 disparities through shared creation and dissemination of public health messages, enhanced connection to existing resources, and incorporation of community perspectives in regional pandemic mitigation policies.
Prognosis of hospitalized patients with cirrhosis and acute kidney disease
Wong, Florence , García–Tsao, Guadalupe , Reddy, K. Rajender , O’Leary, Jacqueline G. , Kamath, Patrick S. , Tandon, Puneeta , Vargas, Hugo E. , Biggins, Scott W. , Fallon, Michael B. , Thuluvath, Paul J. , Maliakkal, Benedict, Subramanian, Ram, Bajaj, Jasmohan S. , Thuluvath, Paul J , Tandon, Puneeta , Wong, Florence , Vargas, Hugo E , Lai, Jennifer C. , Thacker, Leroy R.

Mayo Clinic

Liver International | January 13, 2022 | Volume: 42 | Issue: 4 | Pages: 896-904

10.1111/liv.15154 | PMID 35023264 Get It

AbstractBackgroundThe prognosis of acute kidney disease (AKD), defined as a glomerular filtration rate of <60 ml/min/1.73 m2 or a rise in serum creatinine (sCr) of <50% for <3 months, is not clearly known.AimTo study the prevalence, predictive factors and clinical outcomes in hospitalized cirrhotic patients with AKD.MethodsThe North American Consortium for the Study of End‐Stage Liver Disease prospectively enrolled hospitalized decompensated cirrhotic patients. Patients were separated into those with normal renal function (controls or C), AKD or stage 1 AKI as their worst renal dysfunction per International Club of Ascites definition and compared. Parameters assessed included demographics, laboratory data, haemodynamics, renal and patient outcomes.Results1244 patients with cirrhosis and ascites (C: 704 or 57%; AKD: 176 or 14%; stage 1 AKI: 364 or 29%) with similar demographics were enrolled. AKD patients had similar baseline sCr but higher hospital admission in the previous 6 months, and higher peak sCr, compared to controls, with their peak sCr being lower than that in stage 1 AKI patients (all P < .0001). The in‐hospital and 30‐day survival for AKD patients were intermediary between that for controls and stage 1 AKI patients (96% vs 91% vs 86%, P < .0001). The strongest predictors for AKD development while in hospital were the presence of a second infection (OR: 2.44) and diabetes (OR: 1.53).ConclusionsPatients with AKD had intermediate outcomes between stage 1 AKI and controls. AKD patients, especially those with diabetes and a second infection, need careful monitoring and prompt treatment for AKD to prevent negative outcomes.
Understanding and Application of Daptomycin-Susceptible Dose-Dependent Category for Enterococcus: A Mixed-Methods Study
Adema, Jennifer L. , Lake, Laurel N, Hogan, Breann M. , Tande, Aaron J. , Mara, Kristin C. , Eberly, Allison R. , Rivera, Christina G. , Tande, Aaron , Mara, Kristin C , Eberly, Allison R , Rivera, Christina G , Stevens, Ryan W. , Schuetz, Audrey N.

Mayo Clinic

Open Forum Infectious Diseases | January 12, 2022 | Volume: 9 | Issue: 1 | Pages: No page available

10.1093/ofid/ofab611 | PMID 35036465 Get It

Abstract Background In 2018, the Clinical Microbiology Laboratory at our institution adopted updated daptomycin Enterococcus–susceptible dose-dependent breakpoints. While the introduction of susceptible dose-dependent (SDD) was intended to guide practice toward optimal dosing, the understanding and application of daptomycin SDD breakpoints for enterococci were unknown. Methods This mixed-methods study combined a clinician survey with a retrospective pre–post prescribing analysis. An 8-question survey was distributed to infectious diseases (ID) and internal medicine (IM) clinicians. A retrospective chart review of hospitalized adults with infections due to Enterococcus spp. was conducted before (pre-SDD) and after (post-SDD) adoption of SDD reporting for enterococci. Results Survey response rates were 40 of 98 (41%) for IM and 22 of 34 (65%) for ID clinicians. ID clinicians scored significantly higher than IM clinicians in knowledge of SDD. Chart review of 474 patients (225 pre- vs 249 post-SDD) showed that daptomycin dosage following susceptibility testing was significantly higher post-SDD compared with pre-SDD (8.5 mg/kg vs 6.4 mg/kg; P &lt; .001) with no difference in empiric dosing (6.3 mg/kg vs 6.2 mg/kg; P = .67). Definitive daptomycin use varied between the pre- and post-SDD periods (35.1% vs 16.9%; P &lt; .001). Conclusions The survey revealed that ID clinicians placed more importance on and had more confidence in the SDD category over IM clinicians. SDD reporting was associated with a change in definitive daptomycin dosing. ID specialist involvement is recommended in the care of infections due to enterococci for which daptomycin is reported as SDD given their expertise.
Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study
Ho, Ming‐Fen , Zhang, Cheng, Wei, Lixuan, Zhang, Lingxin, Moon, Irene, Geske, Jennifer R., Skime, Michelle K., Choi, Doo‐Sup, Biernacka, Joanna M., Oesterle, Tyler S., Frye, Mark A., Seppala, Marvin D., Karpyak, Victor M., Li, Hu, Weinshilboum, Richard M., Geske, Jennifer R. , Oesterle, Tyler , Wei, Lixuan , Oesterle, Tyler S , Geske, Jennifer , Ho, Ming-Fen , Zhang, Cheng, Wei, Lixuan, Zhang, Lingxin, Moon, Irene, Skime, Michelle K., Choi, Doo‐Sup, Biernacka, Joanna M., Frye, Mark A., Seppala, Marvin D., Karpyak, Victor M., Li, Hu, Weinshilboum, Richard M.

Mayo Clinic

British Journal of Pharmacology | January 11, 2022 | Volume: 179 | Issue: 13 | Pages: 3330-3345

10.1111/bph.15795 | PMID 35016259 Get It

Background and Purpose Acamprosate is an anti‐craving drug used for the pharmacotherapy of alcohol use disorder (AUD). However, only some patients achieve optimal therapeutic outcomes. This study was designed to explore differences in metabolomic profiles between patients who maintained sobriety and those who relapsed, to determine whether those differences provide insight into variation in acamprosate treatment response phenotypes. Experimental Approach We previously conducted an acamprosate trial involving 442 AUD patients, and 267 of these subjects presented themselves for a 3‐month follow‐up. The primary outcome was abstinence. Clinical information, genomic data and metabolomics data were collected. Baseline plasma samples were assayed using targeted metabolomics. Key Results Baseline plasma arginine, threonine, α‐aminoadipic acid and ethanolamine concentrations were associated with acamprosate treatment outcomes and baseline craving intensity, a measure that has been associated with acamprosate treatment response. We next applied a pharmacometabolomics‐informed genome‐wide association study (GWAS) strategy to identify genetic variants that might contribute to variations in plasma metabolomic profiles that were associated with craving and/or acamprosate treatment outcome. Gene expression data for induced pluripotent stem cell‐derived forebrain astrocytes showed that a series of genes identified during the metabolomics‐informed GWAS were ethanol responsive. Furthermore, a large number of those genes could be regulated by acamprosate. Finally, we identified a series of single nucleotide polymorphisms that were associated with acamprosate treatment outcomes. Conclusion and Implications These results serve as an important step towards advancing our understanding of disease pathophysiology and drug action responsible for variation in acamprosate response and alcohol craving in AUD patients.
Acute-on-Chronic Liver Failure Clinical Guidelines
Bajaj, Jasmohan S. , O’Leary, Jacqueline G. , Long, Millie D. , Wong, Robert J. , Kamath, Patrick S. , Wong, Robert J , Lai, Jennifer C. , Wong, Florence

Mayo Clinic

American Journal of Gastroenterology | January 10, 2022 | Volume: 117 | Issue: 2 | Pages: 225-252

10.14309/ajg.0000000000001595 | PMID 35006099 Get It

In patients with cirrhosis and chronic liver disease, acute-on-chronic liver failure is emerging as a major cause of mortality. These guidelines indicate the preferred approach to the management of patients with acute-on-chronic liver failure and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation process. In instances where the evidence was not appropriate for Grading of Recommendations, Assessment, Development, and Evaluation, but there was consensus of significant clinical merit, key concept statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not only, approach to clinical scenarios.
Bayesian kernel machine regression‐causal mediation analysis
Devick, Katrina L. , Bobb, Jennifer F. , Mazumdar, Maitreyi , Henn, Birgit Claus , Bellinger, David C., Coull, Brent A. , Christiani, David C. , Wright, Robert O. , Williams, Paige L. , Valeri, Linda

Mayo Clinic

Statistics in Medicine | January 7, 2022 | Volume: 41 | Issue: 5 | Pages: 860-876

10.1002/sim.9255 | PMID 34993981 Get It

Greater understanding of the pathways through which an environmental mixture operates is important to design effective interventions. We present new methodology to estimate natural direct and indirect effects and controlled direct effects of a complex mixture exposure on an outcome through a mediator variable. We implement Bayesian Kernel Machine Regression (BKMR) to allow for all possible interactions and nonlinear effects of (1) the co‐exposures on the mediator, (2) the co‐exposures and mediator on the outcome, and (3) selected covariates on the mediator and/or outcome. From the posterior predictive distributions of the mediator and outcome, we simulate counterfactuals to obtain posterior samples, estimates, and credible intervals of the mediation effects. Our simulation study demonstrates that when the exposure‐mediator and exposure‐mediator‐outcome relationships are complex, BKMR‐Causal Mediation Analysis performs better than current mediation methods. We applied our methodology to quantify the contribution of birth length as a mediator between in utero co‐exposure to arsenic, manganese, and lead, and children's neurodevelopmental scores, in a prospective birth cohort in Bangladesh. Among younger children, we found a negative (adverse) association between the metal mixture and neurodevelopment. We also found evidence that birth length mediates the effect of exposure to the metal mixture on neurodevelopment for younger children. If birth length were fixed to its percentile value, the harmful effect of the metal mixture on neurodevelopment is attenuated, suggesting nutritional interventions to help increase fetal growth, and thus birth length, could potentially block the harmful effect of the metal mixture on neurodevelopment.
Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals
Campbell, Kristin L. , Cormie, Prue , Weller, Sarah, Alibhai, Shabbir M.H. , Bolam, Kate A., Campbell, Anna , Cheville, Andrea , Dalzell, Mary-Ann, Hart, Nicolas H. , Higano, Celestia S. , Lane, Kirstin , Mansfield, Sami, Newton, Robert U. , Quist, Morten , Rauw, Jennifer, Rosenberger, Friederike , Mina, Daniel Santa , Winters-Stone, Kerri M., Wiskemann, Joachim , Goulart, Jennifer , Cheville, Andrea L , McNeely, Margaret L , Newton, Robert U , Quist, Morten , Rosenberger, Friederike , Santa Mina, Daniel , Schmitz, Kathryn H , Wiskemann, Joachim , Goulart, Jennifer , Campbell, Anna M , Campbell, Kristin L , Cormie, Prue , Weller, Sarah , Alibhai, Shabbir M. H. , Bolam, Kate A. , Dalzell, Mary-Ann, Hart, Nicolas H. , Higano, Celestia S. , Lane, Kirstin , Mansfield, Sami, Rauw, Jennifer, Winters-Stone, Kerri M.

Mayo Clinic

JCO Oncology Practice | January 6, 2022 | Volume: 18 | Issue: 5 | Pages: e697-e709

10.1200/op.21.00454 | PMID 34990293 Get It

PURPOSE: Exercise has been underutilized in people with advanced or incurable cancer despite the potential to improve physical function and reduce psychosocial morbidity, especially for people with bone metastases because of concerns over skeletal complications. The International Bone Metastases Exercise Working Group (IBMEWG) was formed to develop best practice recommendations for exercise programming for people with bone metastases on the basis of published research, clinical experience, and expert opinion. METHODS: The IBMEWG undertook sequential steps to inform the recommendations: (1) modified Delphi survey, (2) systematic review, (3) cross-sectional survey to physicians and nurse practitioners, (4) in-person meeting of IBMEWG to review evidence from steps 1-3 to develop draft recommendations, and (5) stakeholder engagement. RESULTS: Recommendations emerged from the contributing evidence and IBMEWG discussion for pre-exercise screening, exercise testing, exercise prescription, and monitoring of exercise response. Identification of individuals who are potentially at higher risk of exercise-related skeletal complication is a complex interplay of these factors: (1) lesion-related, (2) cancer and cancer treatment–related, and (3) the person-related. Exercise assessment and prescription requires consideration of the location and presentation of bone lesion(s) and should be delivered by qualified exercise professionals with oncology education and exercise prescription experience. Emphasis on postural alignment, controlled movement, and proper technique is essential. CONCLUSION: Ultimately, the perceived risk of skeletal complications should be weighed against potential health benefits on the basis of consultation between the person, health care team, and exercise professionals. These recommendations provide an initial framework to improve the integration of exercise programming into clinical care for people with bone metastases.